tiprankstipranks
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead initiated with a Buy at Citi
The FlyArrowhead initiated with a Buy at Citi
24h ago
ARWR
Arrowhead Phase 3 SHASTA-3, SHASTA-4 studies met primary endpoints
PremiumThe Fly
Arrowhead Phase 3 SHASTA-3, SHASTA-4 studies met primary endpoints
10d ago
ARWR
Arrowhead announces availability of REDEMPLO for FCS in Germany
PremiumThe Fly
Arrowhead announces availability of REDEMPLO for FCS in Germany
23d ago
ARWR
Arrowhead Pharmaceuticals Earnings Call Signals Confident Expansion
PremiumCompany Announcements
Arrowhead Pharmaceuticals Earnings Call Signals Confident Expansion
24d ago
ARWR
Arrowhead price target raised to $120 from $115 at H.C. Wainwright
PremiumThe Fly
Arrowhead price target raised to $120 from $115 at H.C. Wainwright
1M ago
ARWR
Arrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target
PremiumRatingsArrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target
1M ago
ARWR
Arrowhead price target raised to $104 from $98 at Stifel
Premium
The Fly
Arrowhead price target raised to $104 from $98 at Stifel
1M ago
ARWR
Arrowhead: Strong Phase III Plozasiran Data and Priority Review Voucher Drive Accelerated Path to Market and $3B Global Sales Outlook, Supporting Buy Rating
Premium
Ratings
Arrowhead: Strong Phase III Plozasiran Data and Priority Review Voucher Drive Accelerated Path to Market and $3B Global Sales Outlook, Supporting Buy Rating
1M ago
ARWR
Arrowhead reports Q3 EPS ($1.36), consensus ($1.23)
PremiumThe Fly
Arrowhead reports Q3 EPS ($1.36), consensus ($1.23)
1M ago
ARWR
Arrowhead acquires FDA priority review voucher
PremiumThe Fly
Arrowhead acquires FDA priority review voucher
1M ago
ARWR
Is ARWR a Buy, Before Earnings?
PremiumPre-Earnings
Is ARWR a Buy, Before Earnings?
1M ago
ARWR
Arrowhead price target raised to $123 from $101 at B. Riley
PremiumThe Fly
Arrowhead price target raised to $123 from $101 at B. Riley
1M ago
ARWR
Arrowhead completes enrollment in Phase 3 YOSEMITE trial
PremiumThe FlyArrowhead completes enrollment in Phase 3 YOSEMITE trial
1M ago
ARWR
Arrowhead price target raised to $115 from $100 at H.C. Wainwright
Premium
The Fly
Arrowhead price target raised to $115 from $100 at H.C. Wainwright
1M ago
ARWR
Arrowhead price target raised to $120 from $100 at Morgan Stanley
Premium
The Fly
Arrowhead price target raised to $120 from $100 at Morgan Stanley
2M ago
ARWR
Arrowhead price target raised to $126 from $110 at Piper Sandler
PremiumThe Fly
Arrowhead price target raised to $126 from $110 at Piper Sandler
2M ago
ARWR
Arrowhead price target raised to $115 from $90 at Chardan
PremiumThe Fly
Arrowhead price target raised to $115 from $90 at Chardan
2M ago
ARWR
Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results
PremiumMarket News
Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results
2M ago
ARWR
Arrowhead’s ARO-033 First-in-Human Trial: What Early Safety Progress Means for ARWR Investors
PremiumCompany Announcements
Arrowhead’s ARO-033 First-in-Human Trial: What Early Safety Progress Means for ARWR Investors
2M ago
ARWR
Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
PremiumThe FlyMidday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
2M ago
T
PM
Arrowhead rises 23.4%
Premium
The Fly
Arrowhead rises 23.4%
2M ago
ARWR
Arrowhead rises 22.7%
Premium
The Fly
Arrowhead rises 22.7%
2M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >